Antimicrob Agents Chemother 1994,38(10):2380–2386.PubMedCentralPubMedCrossRef 37. Ohno H, Koga H, Kohno S, Tashiro T, Hara K: Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan. Antimicrob Agents Chemother 1996,40(4):1053–1056.PubMedCentralPubMed

38. Mani C, Selvakumar N, Narayanan S, Narayanan PR: Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis clinical isolates from India. J Clin Microbiol 2001,39(8):2987–2990.PubMedCentralPubMedCrossRef 39. Johnson R, Streicher EM, Louw GE, Warren RM, van Helden PD, Victor TC: Drug Resistance in Mycobacterium tuberculosis. Curr Issues Mol Biol 2009, 8:97–112. 40. Mokrousov AZD1152-HQPA price I, Narvskaya O, Otten T, Limeschenko E, Steklova L, Vyshnevskiy B: High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996 to 2001. Antimicrob Agents Chemother 2002,46(5):1417–1424.PubMedCentralPubMedCrossRef 41. Sajduda A, Brzostek A, Poplawska M, Augustynowicz-Kopec E, Zwolska Z, Niemann S, Dziadek J, Hillemann D: Molecular characterization of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated

in Poland. J Clin Microbiol 2004,42(6):2425–2431.PubMedCentralPubMedCrossRef 42. van Doorn HR, An DD, de Jong MD, Lan NT, Hoa DV, Quy HT, Chau NV, Duy Adriamycin datasheet PM, Tho DQ, Chinh NT, Farrar JJ, Caws M: Fluoroquinolone resistance detection in Mycobacterium tuberculosis with locked nucleic acid probe real-time PCR. Int J Tuberc Lung Dis 2008,12(7):736–742.PubMed 43. Bakonyte D, Baranauskaite A, Cicenaite J, Sosnovskaja A, Stakenas P: Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical isolates in Lithuania. Antimicrob Agents Chemother 2003,47(6):2009–2011.PubMedCentralPubMedCrossRef 44. buy Temsirolimus Tudo G, Gonzalez J,

Obama R, Rodriguez JM, Franco JR, Espasa M, Simarro PR, Escaramis G, Ascaso C, Garcia A, Jimenez De Anta MT: Study of resistance to anti-tuberculosis drugs in five districts of Equatorial Guinea: rates, risk factors, genotyping of gene mutations and molecular epidemiology. Int J Tuberc Lung Dis 2004,8(1):15–22.PubMed 45. Chaoui I, Sabouni R, Kourout M, Jordaan AM, Lahlou O, Elouad R, Akrim M, Victor TC, El Mzibri M: Analysis of isoniazid, streptomycin and ethambutol resistance in Mycobacterium tuberculosis isolates from Morocco. J Infect Dev Ctries 2009,3(4):278–284.PubMed 46. Cho EH, Bae HK, Kang SK, Lee EH: Detection of isoniazid and rifampicin resistance by sequencing of katG, inhA, and rpoB genes in Korea. Korean J Lab Med 2009,29(5):455–460.PubMedCrossRef 47.